OPIOIDS AND THE PHYSIOLOGY OF THE VENTRAL PALLIDUM

阿片类药物与腹侧苍白球的生理学

基本信息

  • 批准号:
    2700823
  • 负责人:
  • 金额:
    $ 17.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1990
  • 资助国家:
    美国
  • 起止时间:
    1990-07-01 至 2000-02-29
  • 项目状态:
    已结题

项目摘要

The ventral pallidum (VP) may be a neurobiological substrate for the motivational aspects of opiate addiction, such as drug craving. Though grossly understudied, the neural adaptations that underlie the enhanced responding that occurs after repeated exposure to opiates likely parallel those mediating drug craving in the addict. Chronic opiates appear to induce long lasting changes in the ventral tegmental area (VTA) and the nucleus accumbens (NA). We hypothesize that VP neurons undergo a persistent adaptation to chronic opiate exposure. This may reflect an alteration in VTA and NA inputs, as well as changes in VP neurons themselves. To test these hypotheses, biochemical and electrophysiological comparisons will be made among these regions in rats that demonstrate morphine-induced sensitization. Specific Aim 1. To determine which aspects of the opioid receptor-mediated signal transduction system are involved in neuronal adaptations to chronic morphine treatments. Alterations in signal transduction may be critical mechanisms by which the brain adapts to chronic exposure to drugs of abuse. The effects of morphine-induced sensitization will be examined by this Aim by measuring G protein levels, adenylyl cyclase activity and immediate early gene induction. The results should indicate the biochemical underpinnings of functional changes seen in Aims 2 and 3. Specific Aim 2. To determine the ability of chronic morphine treatments to alter responses of VP and NA neurons to opioid agonists and antagonists. The opioid receptors that mediate morphine-induced sensitization and the physiological parallels to changes in opioid receptor-effector coupling seen during this sensitization are not known. Experiments in Aim 2 will use extracellular electrophysiology in combination with microiontophoretic application of opioid receptor subtype-specific drugs to provide the first examination of these issues for the VP and NA. Specific Aim 3. To determine if chronic morphine treatments alter opioid modulation of dopaminergic transmission from the VTA to the VP and NA. With extracellular electrophysiology, we recently revealed that opioids modulate dopamine transmission in the VP. As neuromodulation can occur on membrane events that are subthreshold to the generation of an action potential, intracellular recordings of VP and NA neurons in vivo will be used to determine if chronic morphine alters this modulation. Because the VP serves as a major output for the mesolimbic system, studies on this region are critical to understanding the consequences of neural adaptations of the brain's reward system. The proposed experiments should provide new insights for the development of more efficacious therapy for compulsive drug use and craving.
腹侧苍白球(VP)可能是阿片类药物成瘾(如药物渴求)的神经生物学基础。 虽然研究得还不够充分,但神经适应性是重复暴露于阿片类药物后发生的增强反应的基础,可能与成瘾者介导药物渴望的神经适应性相似。 慢性阿片类药物似乎会引起腹侧被盖区(VTA)和伏隔核(NA)的长期变化。 我们假设VP神经元对慢性阿片暴露进行持续适应。 这可能反映了VTA和NA输入的改变,以及VP神经元本身的变化。 为了检验这些假设,将在表现出吗啡诱导的致敏作用的大鼠的这些区域之间进行生物化学和电生理学比较。具体目标1。确定阿片受体介导的信号转导系统的哪些方面参与了神经元对慢性吗啡治疗的适应。 信号转导的改变可能是大脑适应长期暴露于滥用药物的关键机制。 吗啡诱导的致敏作用将通过测量G蛋白水平、腺苷酸环化酶活性和即刻早期基因诱导来检查。 结果应表明目标2和3中所见功能变化的生物化学基础。具体目标2。 确定慢性吗啡处理改变VP和NA神经元对阿片激动剂和拮抗剂的反应的能力。 介导吗啡诱导的致敏作用的阿片受体和在这种致敏作用期间观察到的阿片受体-效应器偶联变化的生理学平行性尚不清楚。 目标2中的实验将使用细胞外电生理学与阿片受体亚型特异性药物的微离子电渗应用相结合,为VP和NA提供对这些问题的首次检查。具体目标3。 确定慢性吗啡治疗是否改变阿片类药物对从腹侧被盖区到VP和NA的多巴胺能传递的调节。 随着细胞外电生理学,我们最近发现,阿片类药物调节多巴胺传输的VP。 由于神经调节可以发生在动作电位产生的阈下膜事件上,因此将使用体内VP和NA神经元的细胞内记录来确定慢性吗啡是否改变这种调节。由于VP是中脑边缘系统的主要输出,因此对该区域的研究对于理解大脑奖励系统的神经适应的后果至关重要。拟议的实验应该为开发更有效的治疗强迫性药物使用和渴望提供新的见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

T. Celeste Napier其他文献

T. Celeste Napier的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('T. Celeste Napier', 18)}}的其他基金

Brain signaling effects of pramipexole-induced impulsivity in parkinsonian rats
普拉克索诱发帕金森病大鼠冲动的脑信号传导效应
  • 批准号:
    8693369
  • 财政年份:
    2014
  • 资助金额:
    $ 17.56万
  • 项目类别:
A novel rodent model of dopamine agonist-induced impulsive control disorders
多巴胺激动剂诱导的冲动控制障碍的新型啮齿动物模型
  • 批准号:
    8093443
  • 财政年份:
    2011
  • 资助金额:
    $ 17.56万
  • 项目类别:
A novel rodent model of dopamine agonist-induced impulsive control disorders
多巴胺激动剂诱导的冲动控制障碍的新型啮齿动物模型
  • 批准号:
    8288065
  • 财政年份:
    2011
  • 资助金额:
    $ 17.56万
  • 项目类别:
5-HT & Medication Development for Methamphetamine Abuse
5-羟色胺
  • 批准号:
    6806980
  • 财政年份:
    2003
  • 资助金额:
    $ 17.56万
  • 项目类别:
5-HT & Medication Development for Methamphetamine Abuse
5-羟色胺
  • 批准号:
    6891352
  • 财政年份:
    2003
  • 资助金额:
    $ 17.56万
  • 项目类别:
5-HT & Medication Development for Methamphetamine Abuse
5-羟色胺
  • 批准号:
    7282521
  • 财政年份:
    2003
  • 资助金额:
    $ 17.56万
  • 项目类别:
5-HT & Medication Development for Methamphetamine Abuse
5-羟色胺
  • 批准号:
    6684479
  • 财政年份:
    2003
  • 资助金额:
    $ 17.56万
  • 项目类别:
5-HT & Medication Development for Methamphetamine Abuse
5-羟色胺
  • 批准号:
    7348805
  • 财政年份:
    2003
  • 资助金额:
    $ 17.56万
  • 项目类别:
5-HT & Medication Development for Methamphetamine Abuse
5-羟色胺
  • 批准号:
    7071178
  • 财政年份:
    2003
  • 资助金额:
    $ 17.56万
  • 项目类别:
OPIOIDS AND THE PHYSIOLOGY OF THE VENTRAL PALLIDUM
阿片类药物与腹侧苍白球的生理学
  • 批准号:
    6041709
  • 财政年份:
    1990
  • 资助金额:
    $ 17.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了